ABBV's oncology sales might have dipped in Q2 as gains from newer drugs face pressure from Imbruvica's ongoing decline.

AstraZeneca AZN is one of the leading drugmakers in the oncology space. Oncology sales (comprising around 41% of ...

PFE's oncology unit is in focus ahead of Q2 results, with key drugs facing both rising demand and market pressure.

AstraZeneca’s anselamimab has failed to show any benefit in patients with light chain amyloidosis in two Phase III trials.

Modella AI has signed a multi-year agreement with AstraZeneca to expedite AI-driven oncology clinical development. The ...

AstraZeneca's Oncology Success: Fueling Future Growth. Jun. 25, 2024 12:54 PM ET AstraZeneca PLC (AZN) Stock, AZNCF Stock SPY, PFE, BMY, MRK, AZN, AZNCF 5 Comments 2 Likes. ALLKA Research.

AstraZeneca, which is working on the drug with Japan's Daiichi Sankyo , opens new tab, said on Monday that Enhertu prolonged survival and slowed the progression of metastatic breast cancer with ...

AstraZeneca Oncology Business Executive Vice-President David Fredrickson said blood-based screenings, AI-assisted drug treatment plans and early diagnosis are 'within our grasp' for the 2040 vision.

About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare ...

ANGLE PLC chief executive Andrew Newland joins Proactive's Stephen Gunnion with news the company has entered a significant contract with AstraZeneca, marking its second major collaboration with a ...

Mondher Mahjoubi will leave his role as head of AstraZeneca's oncology division to serve as the new CEO of Innate Pharma, a French biotech focusing on immuno-oncology therapies, reports Reuters.